#8

IDENTIFICATION OF A SINGLE NUCLEOTIDE POLYMORPHISM IN THE MMP-1 PROMOTER IN CHONDROSARCOMA
Ian Douglas Dickey¹, Sean Patrick Scully (¹Mayo Clinic, Minnesota, United)

CDNA MICROARRAY ANALYSIS OF MESENCHYMAL NEOPLASIA EX VIVO
R. Lor Randall¹, Mark Wade¹, Karen Albritton¹ (¹Huntsman Cancer Institute at the University of Utah, Utah, United States)

HUMAN BREAST CANCER CELLS MODULATE THE SURVIVAL AND ACTIVITY OF OSTEOBLASTS
Matthew J. Allen¹, Sheila A. Moore¹, Timothy A. Damron¹ (¹SUNY Upstate Medical University at Syracuse, New York, United States)

SYNERGISTIC ACTION OF DOXORUBICIN AND TRAIL IN TNF‑ALPHA RESISTANT RHABDOMYOSARCOMA CELLS
Rudy Komdeurl, Coby Meijer¹, Harald J Hoekstra¹, Martine van Zweeden¹, Steven de Jong¹, Jelle Wesseling¹, Eva van den Berg¹, Winette TA van der Graaf¹ (¹Groningen University Hospital, Netherlands)

MORPHOLOGICAL AND BIOLOGICAL HETEROGENEITY OF THREE TUMORIGENIC CELL LINES DERIVED FROM A SINGLE P53-/- OSTEOBLAST‑LIKE CELL LINE, MMC2
Koichi Nishijol, Tomitaka Nakayama¹, Hiroshi Murakami¹, Tomoki Aoyama¹, Takeshi Okamoto¹, Takashi Nakamura¹, Junya Toguchida² (1Department of Orthopaedic Surgery Kyoto University, Kyoto Prqfecture, Japan; ²Institute for Frontier Medical Sciences Kvoto University, Kyoto Prefecture, Japan)

IN VITRO TRANSFORMATION OF THE RB(-/-) MURINE OSTEOBLAST
Takeshi Okamoto¹, Hiroshi Yamamoto¹, Tomoki Aoyama¹, Koichi Nishijo¹, Takeharu Nakamata¹, Taisuke Hosaka¹, Tomitaka Nakayama¹, Takashi Nakamura¹, Junya Toguchida² (¹Department of Orthopaedic Surgery Kyoto University, Japan; ²Institiute fbr Frontier Medical Science Kyoto Univeresity, Japan)

EXPRESION OF THE CHONDROMODULIN‑1 GENE IN OSTESARCOMAS SUGGESTS THE PRESENCE OF OSTEO‑CHONDRAL BIDIRECTIONAL PRECURSOR CELLS
Tomoki Aoyama¹, Takeshi Okamoto¹, Koichi Nishijol, Tatsuya Ishibel, KoYasura¹, Takeharu Nakamata¹, Taisuke Hosaka¹, Tomitaka Nakayama¹, Takashi Nakamura¹, Junya Toguchida² (¹Department of Orthopedic Surgery Kyoto University, Japan: ²Institute for Frontier Medical Science Kyoto University, Japan)

IN VITRO CHEMOSENSITIVITY OF HUMAN SOFT TISSUE SARCOMA TISSUE
Hideo Morioka¹, Hiroo Yabe, Ukei Anazawa, Keiko Miura, Masafumi Kawamura (¹Department of Orthopaedic Surgery School of Medicine Keio University, Tokyo, Japan; ²Department of Surgery School of Medicine Keio University, Tokyo, Japan)

LOW LOCAL RECURRENCE RATE OF LARGE, DEEP‑SEATED, SOFT-TISSUE SARCOMAS WITH RESECTION AFTER INDUCTION (NEOADJUVANT) CHEMOTHERAPY: HISTOLOGICAL ANALYSIS OF CAPSULE FORMATION AND THE ROLE OF ADJUVANT GASTROINTESTINAL STROMAL TUMOUR: THE PATIENT EXPERIENCE
Anne McTieman¹, Robyn Reagon¹, Jeremy Whelan¹ (¹The London Bone and Soft Tissue Tumour Service, London, United Kingdom)

GEMCITABINE AND DOCETAXEL IN SARCOMA
Kirsten M. Leu¹, Mark Zaiupski¹, Vernon Sondak¹, Krisinda Snyder¹, Laurence H. Baker¹ (¹University of Michigan Comprehensive Cancer Center, MI, United States)

GEMCITABINE AND DOCETAXEL IN SARCOMA
Kirsten M. Leu¹, Mark Zaiupski¹, Vernon Sondak¹, Krisinda Snyder¹, Laurence H. Baker¹ (¹University of Michigan Comprehensive Cancer Center, MI, United States)

CELL CYCLE ABNORMALITIES IN GIANT CELL TUMORS
Adel Kuzman¹, Shu Qiu Li¹, Grace Bradley¹, Robert Bell¹, Jay Wunder¹, Joel Werier¹, Rita Kandel¹ (¹Mount Sinai Hospital, Ontario, Canada)

CYTOGENETIC ANALYSIS OF 29 MYXOID/ROUND CELL LIPOSARCOMAS
Brian P Rubin¹, Christopher B Hagen¹, Thomas H Norwood¹, Christine M Disteche¹, Karen Swisshelm¹, Scott M Schuetze¹, Janet F Eary¹, James D Bruckner¹, Ernest U Conrad¹ (¹University of Washington Medical Center, Washington, United States)

DIFFERENTIAL EXPRESSION OF CELL CYCLE GI CYCLINS IN EWING TUMORS AND RHABDOMYOSARCOMA
Jingsong Zhang¹, Deborah E. Schofield¹, Timothy J. Triche¹ (¹Children’s Hospital Los Angeles Research Institute, California, United States)

A PREVIOUSLY UNREPORTED CASE OF BONE METASTASTS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR IN A PATIENT WITH TYPE I NEUROFIBROMATOSIS (VON RECKLINGHAUSEN’S DISEASE)
John Christopher Herzog¹, Manjula Bansal², Yehuda Kleinman¹, Timothy Shane Shawl, John R. Denton¹ (¹Saint Vincents Catholic Medical Centers, NY United States; ²Hospital for Special Surgery, NY United States)

Pediatric Oncology

RANDOMIZED TRIAL OF AMIFOSTINE WITH HIGH DOSE ALKYLATOR THERAPY IN EWING SARCOMA: A POG/CCG INTERGROUP STUDY
Mark L. Bernstein¹, Meenakshi Devidas¹ (¹Children’s Oncology Group, United States)

IMMUNOHISTOCHEMICAL BASIS FOR COMBINATION RADIOPROTECTANT TREATMENT WITH AMIFOSTINE AND PENTOXIFYLLINE FOR GROWTH PLATE PROTECTION DURING IRRADIATION
Timothy A. Damron¹, Sharad Mathur¹, Judy Strauss¹, Lee Reichel I, Bryan Margulies¹, Yi Yang¹, Steve Landas¹, Cornelia Farnum², William Grant¹, Joseph A. Spadaro¹ (¹SUNY Upstate Medical University at Syracuse, New York, United States; ²Cornell University College of Veterinary Medicine, New York, United States)

RADIATION THERAPY IN THE MANAGEMENT OF GIANT CELL TUMOR OF BONE
James J Caudell¹, Matthew T Ballol, Gunar K Zagars¹, Valerae 0 Lewis¹, Rex A Marco¹, Kristin L Weber¹, Patrick P Lin¹, Robert S Benjamin¹, Adel K El-Naggar¹, Alan W Yasko¹ (¹UT MD Anderson Cancer Center United States)

NOVEL RADIOPROTECTANT DRUGS OTHER THAN AMIFOSTINE FOR SPARING RADIATION‑INDUCED DAMAGE TO THE PHYSIS
Timothy A. Damron¹, Joseph A. Spadaro¹, Jason Horton¹, Bryan Margulies¹, Judy Strauss¹, Cornelia N. Farnum² (¹SUNY Upstate Medical University at Syracuse, New York, United States; ²Cornell University College of Veterinary Medicine, New York, United States)

EXTERNAL BEAM RADIATION IS AN EFFECTIVE ADJUVANT THERAPY FOR CLEAR CELL SARCOMA
James Hayden², David Zurakowski³, Thomas Delaney¹, Francis Hornicek¹, Henry Mankin¹, Mark Gebhardt¹ (¹Massachusetts General Hospital, Massachusetts, United States; ²Oregon Health and Sciences University, Oregon, United States; ³The Children’s Hospital Boston, MA, United States)

DEDIFFERENTIATED CHONDROSARCOMA: UPDATED OUTCOMES WITH CURRENT TREATMENT APPROACHES AS COMPARED TO THOSE PRIOR TO 1984
Ian Douglas Dickey¹, Peter S. Rose¹ (¹Mayo Clinic, Minnesota, United States)

CD44S IS A PROGNOSTIC MARKER IN SOFT TISSUE SARCOMA
Matthias Peiper¹, Take‑Sato¹, Antje Heinecke¹, Claus F. Fisenberger¹, Wolfram Trudo Knoefell, Jakob R. lzbicki¹ (¹Department of Surgery University of Hamburg, Germany)

MALIGNANT FIBROUS HISTOCYTOMA OF THE EXTREMITIES AND TRUNK—AN INSTITUTIONAL REVIEW
Alexandra Koenig¹, Matthias Peiper¹, Wolfram Trudo Knoefel¹, Jakob R. lzbicki¹ (¹Department of Surgery University Hospital Hamburg, Germany)

PROLIFERATION AND APOPTOSIS ARE INDEPENDENT PROGNOSTIC PARAMETERS IN HUMAN LIPOSARCOMA
Eike Gert Achilles3, Sabine Laschl, David Zurakowski³, J Schulz¹, Matthias Peiper¹, W D Beecken², Xavier Rogiers¹ (¹Department of Surgery University Hospital Eppendorf Germany; ²Clinic for Urology University Hospital Frankfurt, Germany; ³Department of Research Statistics Children’s Hospital Boston, United States)

RECONSTRUCTION WITH SCAPULAR ENDORPROSTHESIS PROVIDES SUPERIOR RESULTS AFTER TOTAL SCAPULAR RESECTION: SURGICAL TECHNIQUE AND COMPARISON TO PATIENTS WITHOUT ENDOPROSTHETIC RECONSTRUCTION
Felasfa M Wodajol, Jacob Bickels², James C Wittig³, Kristen Kellar-Graney¹, Yehuda Kollender², Isaac Metier², Martin M Malawer¹ (¹Washington Cancer Institute, DC, United States; ²Tel Aviv Sourasky Medical Center, Israel; ³NYU Medical Center Tisch Hospital, NY United States)

THE IMPORTANCE OF TUMOUR VOLUME TO DISTAL FEMORAL VOLUME RATIO IN THE PRESENTATION OF GIANT CELL TUMOURS OF THE DISTAL FEMUR
Lee Jeys¹, Raj Suneja¹, Simon Carter¹, Robert Grimer¹ (¹Royal Orthopaedic Hospital Oncology Service, Birmingham, United Kingdom)